REFERENCES
- Swarbrick J. STP Pharma Pratiques 1996; 6: 53
- Salsa T., Veiga F., Pina M. E. Drug. Dev. Ind. Pharm. 1997; 23: 929
- Feely L. C., Davis S. S. Int. J. Pharm. 1988; 44: 131
- Wan L. S. C., Heng P. W. S., Wong L. F. Int. J. Pharm. 1991; 73: 111
- Skoug J. W., Mikelsons M. V., Vigneron C. N., Stemn N. L. J. Controlled Release 1993; 27: 227
- Pham A. T., Lee P. I. Pharm. Res. 1994; 11: 1379
- Tahara K., Yamamoto K., Nishiahata T. Int. J. Pharm. 1996; 133: 17
- Loftsson T., Brewster M. E. J. Ph. Sci. 1996; 85: 1017
- Irie T., Uekama K. J. Pharm. Sci. 1997; 86: 147
- Stella V. J., Rajewski R. A. Pharm. Res. 1997; 14: 556
- Arias M. J., Muñoz P., Moyano J. R., Ginés J. M., Novak C. Int. J. Pharm. 1996; 143: 113
- Arias M. J., Moyano J. R., Ginés J. M. Int. J. Pharm. 1997; 153: 181
- Mitrevej A., Sinchaipanid N., Junyaprasert V., Warintournuwat L. Drug Dev. Ind. Pharm. 1996; 22: 1237
- Roselli C., Perly B., Duchêne D., Wouessidjewe D. STP Pharma Sci. 1999; 9: 267
- Veiga F., Salsa T., Pina M. E. Drug Dev. Ind. Pharm. 1997; 23: 547
- U.S. Pharmacopeial Convention. United States Pharmacopeia 23. Author, Rockvile, MD 1995; 1791–2049,2053
- Higuchi T., Connors K. A. Adv. Anal. Chem. Instrum. 1965; 4: 117
- Pina M. E., Veiga F. Third Spanish-Portuguese Conference on Controlled Drug Delivery. 1998. 71
- Ammar H. O., Ghorab M., El-Nahas S. A., Ghorab M. M. Pharmazie 1996; 51: 42
- Blanco J., Vila-Jato J. L., Otero F., Anguiano S. Drug Dev. Ind. Pharm. 1991; 17: 943
- Yazan Y., Summu M. STP Pharma Sci. 1994; 4: 128